Nomura Holdings Inc Bristol Myers Squibb CO Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

A detailed history of Nomura Holdings Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nomura Holdings Inc holds 38,992 shares of BMY stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,992

Previous 82,728 52.87%

Holding current value

$2.25 Million

Previous $3.44 Million 41.28%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $1.73 Million - $2.26 Million	-43,736 Reduced 52.87%	38,992 $2.02 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $1.02 Million - $1.34 Million	25,371 Added 44.23%	82,728 $3.44 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $2.75 Million - $3.12 Million	57,357 New	57,357 $3.11 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $76,210 - $90,940	1,572 Added 1.98%	80,803 $4.15 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $1.94 Million - $2.16 Million	33,446 Added 73.05%	79,231 $4.6 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $2.92 Million - $3.24 Million	45,785 New	45,785 $2.93 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $36.2 Million - $42.8 Million	528,135 Added 556.92%	622,966 $43.1 Million
Q3 2022 Nov 15, 2022	BUY	$0.13 - $76.84 $9,271 - $5.48 Million	71,316 Added 303.28%	94,831 $6.49 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $23.2 Million - $25.6 Million	-319,608 Reduced 93.15%	23,515 $1.72 Million
Q1 2022 May 18, 2022	BUY	$61.48 - $73.72 $7.29 Million - $8.74 Million	118,534 Added 52.78%	343,123 $24.2 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $4.74 Million - $5.52 Million	88,317 Added 64.81%	224,589 $13.5 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $676,904 - $792,906	11,440 Added 9.16%	136,272 $7.94 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $839,375 - $914,080	-13,558 Reduced 9.8%	124,832 $8.05 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $5.67 Million - $6.38 Million	-95,607 Reduced 40.86%	138,390 $8.46 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $11.2 Million - $12.6 Million	193,237 Added 474.08%	233,997 $14.1 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $2.25 Million - $2.49 Million	-39,098 Reduced 48.96%	40,760 $2.39 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $316,969 - $370,568	5,782 Added 7.81%	79,858 $4.57 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $17.1 Million - $24.8 Million	-367,502 Reduced 83.22%	74,076 $4.04 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $16.2 Million - $21.2 Million	329,551 Added 294.17%	441,578 $27.3 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $6.84 Million - $8.11 Million	-159,996 Reduced 58.82%	112,027 $5.6 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $113 Million - $125 Million	-2,539,052 Reduced 90.32%	272,023 $12.5 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $127 Million - $151 Million	2,805,995 Added 55236.12%	2,811,075 $133 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $45,493 - $58,993	933 Added 22.5%	5,080 $262,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $1.51 Million - $1.7 Million	-27,294 Reduced 86.81%	4,147 $257,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $17.2 Million - $21.5 Million	-340,985 Reduced 91.56%	31,441 $1.24 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $26.9 Million - $31 Million	-449,552 Reduced 54.69%	372,426 $23.5 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $22.3 Million - $25.7 Million	372,426 Added 82.84%	821,978 $51.1 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $3.44 Million - $3.75 Million	-57,355 Reduced 11.31%	449,552 $27.5 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $28 Million - $32.3 Million	506,907	506,907 $32.1 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Bristol Myers Squibb CO Transaction History